CD4 and Alzheimer disease: EA exerts therapeutic effects on persistent itch and skin inflammation in AD mice by activating CB2R, thereby inhibiting mast cell and CD4+ T cell proliferation and the expression of associated inflammatory factors, as well as downstream ERK phosphorylation.